Confirming a KIT mutation and assessing disease spread are critical initial steps for GIST management. Understanding the mutational profile helps tailor treatment, as some mutations may resist Gleevec ...
GISTs are rare tumors originating from the GI tract's supporting structures, often discovered incidentally during endoscopies. They are driven by specific genetic mutations, which influence tumor ...